Abstract
BMT is potentially a cure for hematopoietic disorders; however, the beneficial effects are accompanied by the presence of GVHD. Hanash and Levy have proposed an innovative approach of injection of CD4(+)CD25(+) T cells to prevent GVHD and facilitate donor engraftment while maintaining immune competence
Original language | English |
---|---|
Pages (from-to) | 1375 - 1376 |
Number of pages | 2 |
Journal | Blood |
Volume | 105 |
Issue number | 4 |
Publication status | Published - 2005 |